Mandate

Vinge advises Swedish Match in relation to Scandinavian Tobacco Group’s listing on Nasdaq Copenhagen

February 19, 2016

Vinge advised Swedish Match AB in relation to Scandinavian Tobacco Group A/S’s listing on Nasdaq Copenhagen. Scandinavian Tobacco Group (STG) is a world leading manufacturer of cigars and pipe tobacco.

A prospectus was published on 28 January 2016 and the first day of trading on Nasdaq Copenhagen was on 10 February 2016. The price in the offering was set at DKK 100 per share, corresponding to a market capitalisation of DKK 10 billion for STG.

Swedish Match owned, through Swedish Match Cigars Holding AB, 49 percent of STG before the offering and owns 31.2 percent of STG after completion of the offering and prior to any exercise of the overallotment option.

Vinge’s team primarily consisted of Charlotte Levin, Jonas Johansson, Joakim Hagberg, Amanda Knutsson, Malte Hedlund and Maria Schultzberg.

Related

Vinge advises Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun

Vinge is advising Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun from Dalafast. The acquisition comprises four properties with a total of 23,200 square metres of retail space, which together constitute Tallen’s largest retail area.
November 11, 2026

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026